Trade Mark Journal No.2026/045 6 November 2026

WO0000001726309 (5)

Office of origin: United States of America

Date of International Registration:31 March 2023
Date of designation in the UK: 21 August 2026
Image for mark 1726309 ISYMBILD

Class 5
Monoclonal antibodies for medical purposes; antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprised of apitegromab; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders.

Scholar Rock, Inc.

Representative: Douglas R. Wolf Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA